Bempikibart (ADX-914) is a human anti-IL-7Rα antibody that blocks the IL-7 and TSLP pathways, which have been implicated in driving T cell-mediated pathological processes in autoimmune diseases. Q32 ...

Woodruff started dating the Boyz n the Hood star in 1989 and put a ring on him in 1992; of their 4 children, 2 shun the spotlight, but the others are making their way in the entertainment industry ...

FLINT, Mich. (WJRT) - Students and staff in Flint Community Schools gathered Thursday as the final piece of steel was signed and placed for the school district's newest building in more than 50 years.

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min This week, one Waltham biotech ...

Despite the failure of an eczema trial in December, Q32 Bio is sticking with bempikibart. But a phase 2-stage complement inhibitor and a number of the biotech’s “valued colleagues” won’t be so lucky.

Bryn joined 10TV from WEWS in Cleveland, where she won multiple Emmys for weather coverage and the East Palestine train derailment during her time in northeast Ohio. Bryn started her career in Dayton ...

This large and complex expansion of a biologic medicine manufacturing plant increased capacity 75% by adding three production bioreactors, each 15,400 liters, as well as associated seed reactors and ...

Shares of Q32 Bio QTTB lost nearly 77% yesterday after it reported mixed results from two separate phase IIa studies evaluating its investigational drug bempikibart one in atopic dermatitis (AD or ...

On Wednesday, Q32 Bio Inc. (NASDAQ:QTTB) revealed topline results from the SIGNAL-AA Phase 2a signal finding trial evaluating bempikibart (ADX-914) for alopecia areata (AA). The company plans to ...

Is QTTB a bargain right now? The fastest way to find out is with our Fair Value calculator. We use a mix of 17 proven industry valuation models for maximum accuracy. Get the bottom line for QTTB plus ...

Investing.com-- Oppenheimer slashed its price target on Q32 Bio Inc (NASDAQ:QTTB) after the firm released mixed results from two ongoing phase 2 trials for its Bempikibart treatment. Oppenheimer ...

Q32 Bio (QTTB) announced topline results from the SIGNAL-AA Phase 2a signal finding clinical trial evaluating bempikibart, or ADX-914, which identified encouraging clinical activity in patients with ...